Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
Ekso Bionics Holdings (Nasdaq: EKSO), a leader in medical and industrial exoskeleton technology, has announced its participation in the 15th Annual Craig-Hallum Alpha Select Conference on November 19, 2024, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ekso Bionics Holdings (Nasdaq: EKSO), a leader in medical and industrial exoskeleton technology, has announced its participation in the 15th Annual Craig-Hallum Alpha Select Conference on November 19, 2024, in New York. CEO Scott Davis and CFO Jerome Wong will conduct one-on-one meetings with institutional investors during the event. Interested investors should contact their Craig-Hallum representative to schedule meetings.
Details
News Market Reaction – EKSO
The recorded move for EKSO in the trading session of this news was -0.65%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating at the 15th Annual Craig-Hallum Alpha Select Conference taking place in New York on Tuesday, November 19, 2024.
Management will be participating in one-on-one meetings with institutional investors throughout the conference. For those interested in a meeting, please contact your Craig-Hallum representative.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
Contact:
David Carey
212-867-1768
investors@eksobionics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.